• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效薄层色谱法同时定量测定胶囊剂型中盐酸氟桂利嗪和盐酸普萘洛尔的方法的建立与验证

Development and Validation of a HPTLC Method for Simultaneous Quantitation of Flunarizine Dihydrochloride and Propranolol Hydrochloride in Capsule Dosage Form.

作者信息

Shivarkar N A, Dudhe P B, Nagras M A

机构信息

Department of Pharmaceutical Chemistry, Sinhgad College of Pharmacy, Vadgaon (Bk), Pune-411 041, India.

出版信息

Indian J Pharm Sci. 2013 May;75(3):364-8. doi: 10.4103/0250-474X.117418.

DOI:10.4103/0250-474X.117418
PMID:24082355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3783757/
Abstract

A simple, precise, accurate, and rapid high-performance thin layer chromatographic method has been developed and validated for the simultaneous quantitation of flunarizine dihydrochloride and propranolol hydrochloride in a combined capsule dosage form. The method was carried out on precoated silica gel 60 F254 TLC aluminum plate, (20×10 cm(2)). The solvent system was ethyl acetate:methanol:glacial acetic acid in the proportion of 8:1:1, (v/v/v). R f value for flunarizine dihydrochloride and propranolol hydrochloride was found to be 0.62±0.02 and 0.18±0.02, respectively. The linearity regression analysis for calibration showed 0.999 and 0.999 for flunarizine dihydrochloride and propranolol hydrochloride with respect to peak area and height in the concentration range of 50-350 ng/spot and 500-3500 ng/spot, respectively. Accuracy of recovery studies was found to be 98-100.28 and 99.11-99.45% for flunarizine dihydrochloride and propranolol hydrochloride, respectively. The amounts of drug in marketed formulation were 100.5 and 101.25% of flunarizine dihydrochloride and propranolol hydrochloride, respectively. The method developed can be used for routine analysis in bulk drug and capsule dosage form.

摘要

已开发并验证了一种简单、精确、准确且快速的高效薄层色谱法,用于同时定量复方胶囊剂型中盐酸氟桂利嗪和盐酸普萘洛尔的含量。该方法在预涂硅胶60 F254 TLC铝板(20×10 cm(2))上进行。溶剂系统为乙酸乙酯:甲醇:冰醋酸,比例为8:1:1(v/v/v)。盐酸氟桂利嗪和盐酸普萘洛尔的Rf值分别为0.62±0.02和0.18±0.02。校准的线性回归分析表明,盐酸氟桂利嗪和盐酸普萘洛尔在浓度范围分别为50 - 350 ng/点和500 - 3500 ng/点时,峰面积和峰高的线性相关系数分别为0.999和0.999。回收率研究的准确度分别为:盐酸氟桂利嗪98 - 100.28%,盐酸普萘洛尔99.11 - 99.45%。市售制剂中药物含量分别为盐酸氟桂利嗪的100.5%和盐酸普萘洛尔的101.25%。所开发的方法可用于原料药和胶囊剂型的常规分析。

相似文献

1
Development and Validation of a HPTLC Method for Simultaneous Quantitation of Flunarizine Dihydrochloride and Propranolol Hydrochloride in Capsule Dosage Form.高效薄层色谱法同时定量测定胶囊剂型中盐酸氟桂利嗪和盐酸普萘洛尔的方法的建立与验证
Indian J Pharm Sci. 2013 May;75(3):364-8. doi: 10.4103/0250-474X.117418.
2
Development and Validation of HPTLC Method for Simultaneous Determination of Amlodipine Besylate and Metoprolol Succinate in Bulk and Tablets.高效薄层色谱法同时测定原料药及片剂中苯磺酸氨氯地平和琥珀酸美托洛尔的方法开发与验证
Indian J Pharm Sci. 2012 Mar;74(2):152-6. doi: 10.4103/0250-474X.103849.
3
A High-Performance Thin Layer Chromatography (HPTLC) Method for Simultaneous Determination of Diphenhydramine Hydrochloride and Naproxen Sodium in Tablets.一种同时测定片剂中盐酸苯海拉明和萘普生钠的高效薄层色谱法
Anal Chem Insights. 2015 Dec 3;10:47-51. doi: 10.4137/ACI.S31506. eCollection 2015.
4
Stability-Indicating TLC-densitometric determination of nebivolol hydrochloride in bulk and pharmaceutical dosage form.稳定性指示薄层色谱-密度法测定原料药及制剂中盐酸奈必洛尔的含量
J Chromatogr Sci. 2010 Feb;48(2):109-13. doi: 10.1093/chromsci/48.2.109.
5
Stability-indicating HPTLC determination of ambroxol hydrochloride in bulk drug and pharmaceutical dosage form.稳定性指示高效薄层色谱法测定原料药及药物制剂中盐酸氨溴索的含量
J Chromatogr Sci. 2010 Jan;48(1):45-8. doi: 10.1093/chromsci/48.1.45.
6
HPTLC Method for the Simultaneous Estimation of Valsartan and Hydrochlorothiazide in Tablet Dosage Form.高效薄层色谱法同时测定片剂剂型中缬沙坦和氢氯噻嗪的含量
Indian J Pharm Sci. 2009 Jan;71(1):72-4. doi: 10.4103/0250-474X.51967.
7
Simultaneous HPTLC Determination of Rabeprazole and Itopride Hydrochloride From Their Combined Dosage Form.同时用高效薄层色谱法测定雷贝拉唑和盐酸伊托必利复方制剂中二者的含量。
Indian J Pharm Sci. 2008 May-Jun;70(3):366-8. doi: 10.4103/0250-474X.43004.
8
Development and validation of a HPTLC method for Estimation of Duloxetine Hydrochloride in Bulk Drug and in Tablet Dosage Form.高效薄层色谱法测定原料药及片剂剂型中盐酸度洛西汀的方法开发与验证
Indian J Pharm Sci. 2008 Mar-Apr;70(2):233-6. doi: 10.4103/0250-474X.41463.
9
Development and Validation of a HPTLC Method for the Estimation of Sumatriptan in Tablet Dosage Forms.用于估算片剂剂型中舒马曲坦的高效薄层色谱法的开发与验证
Indian J Pharm Sci. 2008 Nov;70(6):831-4. doi: 10.4103/0250-474X.49138.
10
Validated HPTLC method of analysis for artemether and its formulations.蒿甲醚及其制剂的验证高效薄层色谱分析方法。
J Pharm Biomed Anal. 2007 Feb 19;43(3):839-44. doi: 10.1016/j.jpba.2006.08.029. Epub 2006 Oct 12.

本文引用的文献

1
Quantitative analysis of propranolol hydrochloride by high performance thin layer chromatography.高效薄层色谱法对盐酸普萘洛尔进行定量分析。
Indian J Pharm Sci. 2008 May-Jun;70(3):395-8. doi: 10.4103/0250-474X.43016.
2
Determination of hydrochlorothiazide, triamterene and propranolol hydrochloride by the spectrophotometric method and high-performance liquid chromatography (HPLC).采用分光光度法和高效液相色谱法(HPLC)测定氢氯噻嗪、氨苯蝶啶和盐酸普萘洛尔。
Acta Pol Pharm. 2001 Sep-Oct;58(5):339-44.
3
Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial.
普萘洛尔与氟桂利嗪及氟桂利嗪联合普萘洛尔用于无先兆偏头痛预防的比较。一项双盲试验。
Arq Neuropsiquiatr. 1997 Sep;55(3B):536-41. doi: 10.1590/s0004-282x1997000400003.
4
Liquid chromatographic determination of flunarizine dihydrochloride in the presence of its degradation product.
J Pharm Biomed Anal. 1995 May;13(6):777-84. doi: 10.1016/0731-7085(95)01266-n.
5
A sensitive gas chromatographic method for the determination of propranolol in human plasma.一种用于测定人血浆中普萘洛尔的灵敏气相色谱法。
J Chromatogr. 1973 Sep 26;84(2):347-53. doi: 10.1016/s0021-9673(01)91714-5.
6
Flunarizine in migraine prophylaxis: the clinical experience.氟桂利嗪预防偏头痛:临床经验
J Cardiovasc Pharmacol. 1991;18 Suppl 8:S21-6.